Suchergebnisse - "Sarilumab"

PubPharm (51)

1

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

enthalten in: Arthritis research & therapy | 2023

von Schmidt, W. | Dasgupta, B. | Sloane, J. | +13

2

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

enthalten in: Arthritis Research & Therapy | 2023

von Schmidt, W. | Dasgupta, B. | Sloane, J. | +13

3

Efficacy and safety of interleukin-6 receptor antagonists in adult patients admitted to intensive care unit with COVID-19 : A systematic review and meta-analysis of randomized controlled trials

enthalten in: Preventive medicine reports | 2023

von Peng, R. | Yang, T. | Tong, Y. | +7

4

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19 : a natural experiment due to drug shortages

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Swets, M. | Moss, R. | Kor, F. | +10

5

Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19 : a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)

enthalten in: EClinicalMedicine | 2023

von Mastrorosa, I. | Gagliardini, R. | Segala, F. | +92

6

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Gallagher, J. | Morgan, R.

CommentOn: Clin Microbiol Infect. 2023 Jan;29(1):13-21. - PMID 35863630

7

Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids : a systematic review and meta-analysis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Albuquerque, A. | Eckert, I. | Tramujas, L. | +4

CommentIn: Clin Microbiol Infect. 2023 Jan;29(1):7-9. - PMID 36257548

8

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages

in: International Journal of Infectious Diseases | 2023

von Maaike C. Swets | Rob J. Moss | Flip Kor | +10

9

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

in: Arthritis Research & Therapy | 2023

von Wolfgang A. Schmidt | Bhaskar Dasgupta | Jennifer Sloane | +13

10

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019

enthalten in: BMC infectious diseases | 2022

von Gao, Q. | Yin, X. | Tan, B. | +5

1
2
3
4
5
6
Nächster »
[6]